Abstract
Topoisomerase II alterations in the drug resistant small cell lung cancer cell line H209/V6: S.E.L. Mirski, K.C. Almquist, C.D. Evans, B.G. Campling and S.P.C. Cole. Departments of Oncology and Pharmacology, Queen's University, Kingston, Canada K7L 3N6
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
